CRAMS market in India valued at $895 million: Study

• IBTimes RSS
• Print
• E-Mail
• digg
• Del.icio.us

The momentum gained by this segment of the pharmaceutical industry is worth noting. Over the last five years the CRAMS industry has been contributing close to eight percent of the Indian pharmaceutical business.

Factors like a vast expanse of specialty hospitals with state-of-the-art facilities (nearly 700,000 hospital beds and 221 medical colleges); large English speaking population and rich talent pool; diverse population - large and diverse gene pool; increasing number of chronic diseases and a combination of diseases characteristic of developing and the developed countries is expected to propel the CRAMS industry to grow at a CAGR of nearly 32 percent from 2006 to 2013.

Frost and Sullivan is set to release the study titled 'The Indian Contract Research and Manufacturing Services market' during the CRAMS SUMMIT 2007 - Emerging Opportunities and Business Models to be held on April 27, 2007 at the JW Marriott Hotel, Mumbai.

The report offers coverage on the composition of the CRAMS market and its value chain components.

Additionally, it highlights the factors propelling the growth of this market in India, which is slated to be a driver for the Indian pharmaceutical and life sciences industry.

The study looks at the market composition, growth, drivers and restraints, challenges and regulatory aspects that affect each of the value chain components and is based on the industry knowledge collected through discussions with the key industry players and published information.

The coveted event will focus on the emerging opportunities and business models in the much talked about Contract Research and Manufacturing Services industry in India.